[en] AMPA receptor potentiators belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides have been found to be of great interest as cognitive enhancers. Previous structure–activity relationships have demonstrated the importance for activity of the nature of the substituent at the 7-position of the heterocycle. This work aims to explore the impact on AMPA potentiation of the introduction of different aryl and aralkyl ester or aryl amide groups at the 7-position. The new synthesized compounds were evaluated as AMPA receptor potentiators by examining their effect on rat brain primary cell cultures on AMPA-evoked membrane depolarisation using fluorescent membrane potential dyes and on imaging-based plate reader. The most potent compound of this series was 2-methylphenyl 4-methyl- 3,4-dihydro-2H-1,2,4-benzothiadiazine-7-carboxylate 1,1-dioxide 16c which provoked a strong potentiation of AMPA current with a potency close to that reported for the best reference compounds of the benzothiadiazine class (i.e cyclothiazide). This work also revealed that only the ortho-substitution of the phenyl group of 1,2,4-benzothiadiazine-7-carboxylate esters provided potent AMPA receptor potentiators opening the way to further chemical exploration.
Research Center/Unit :
Laboratoire de Chimie Pharmaceutique, CIRM, Université de Liège Institut de recherches Servier
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
M. Crair, Curr. Opin. Neurobiol., 1999, 9, 88-93.
S. Maren and M. Baudry, Neurobiology of Learning and Memory, 1995, 63, 1-18.
E. Graindorge, P. Francotte, S. Boverie, P. de Tullio and B. Pirotte, Curr. Med. Chem., 2004, 4, 95-103.
M. Beal, Curr. Opin. Neurobiol., 1992, 2, 657-662.
G. Lynch, Curr. Opin. Pharmacol., 2004, 4, 4-11.
M. D. Black, A Review of Preclinical Data, Psychopharmacology., 2005, 179, 154-163.
P. Francotte, P. de Tullio, P. Fraikin, S. Counerotte, E. Goffin and B. Pirotte, Recent Pat. CNS Drug Discovery, 2006, 1, 239-246.
K. Partin, D. Patneau, C. Winters, M. Mayer and A. Buonanno, Neuron, 1993, 11, 1069-1082.
M. Bertolino, M. Baraldi, C. Parenti, D. Braghiroli, M. Di Bella, S. Vicini and E. Costa, Receptor Channel., 1993, 1, 267-278.
C. P. Ptak, A. H. Ahmed and R. E. Oswald, Biochemistry, 2009, 48, 8594-8602.
H. Hald, P. K. Ahring, D. B. Timmermann, T. Liljefors, M. Gajhede and J. S. Kastrup, J. Mol. Biol., 2009, 391, 906-917.
B. Pirotte, T. Podona, O. Diouf, P. de Tullio, P. Lebrun, L. Dupont, F. Somers, J. Delarge, P. Morain, P. Lestage, J. Lepagnol and M. Spedding, J. Med. Chem., 1998, 41, 2946-2959.
P. Francotte, P. de Tullio, T. Podona, O. Diouf, P. Fraikin, P. Lestage, L. Danober, J. Y. Thomas, D. H. Caignard and B. Pirotte, Bioorg. Med. Chem., 2008, 16, 9948-9956.
P. Lestage, L. Danober, B. Lockhart, A. Roger, C. Lebrun, J. L. Robin, P. Desos and A. Cordi, Res. Pract. Alzheimer's Dis., 2002, 6, 253-259.
P. Francotte, P. de Tullio, E. Goffin, G. Dintilhac, E. Graindorge, P. Fraikin, P. Lestage, L. Danober, J. Y. Thomas, D. H. Caignard and B. Pirotte, J. Med. Chem., 2007, 50, 3153-3157.
P. Francotte, E. Goffin, P. Frainkin, P. Lestage, J. C. Van Heugen, L. Danober, J. Y. Thomas, P. Chiap, D. H. Caignard, B. Pirotte and P. de Tullio, J. Med. Chem., 2010, 53, 1700-1711.
J. T. Chou and P. C. Jurs, Journal of Chemical Information and Modeling, 1979, 19, 172-178.
Y. Zhao, J. Jona, D. T. Chow, H. Rong, D. Semin, X. Xia, R. Zanon, C. Spancake and Ed. Maliski, Rapid Commun. Mass Spectrom., 2002, 16, 1548-1555.
C. F. Bigge and S. S. Nikam, Expert Opin. Ther. Pat., 1997, 7, 1099-1114.
J. J. Buccafusco, T. Weiser, K. Winter, K. Klinder and A. V. Terry Jr, Neuropharmacology, 2004, 46, 10-22.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.